We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Liquid supplements are a faster acting and a more efficient way for the body to absorb key active ingredients than taking pills. Our scientists have developed formulations involving leading active ingredients such as collagen in order to create the perfect wellness solution in every bottle. Each LQ bottle is packed full of 9 or more active ingredients all in one easy to drink, daily 50 m bottle.
days to go: Expired investment: £355,000
Comesto is a peer to peer web and app based service that enables professional food buyers to purchase directly from suppliers.  They are a membership funded trading platform.  The platform gives their members access to the whole market eliminating single brochures.  Comesto offers industry buyers a complete purchasing, invoicing and scheduling management service and for suppliers their aim is to provide a simple cost effective way to increase sales.  
days to go: Expired investment: £34,970
Kiddyum have won multiple awards for their nutritious and delicious frozen meals for young children. They are currently stocked in over 320 sainsbury's nationwide and on Ocado.com. All ready meals are made from natural ingredients with no added sugar, preservatives, GM ingredients or artificial colours or flavours.
days to go: Expired investment: £61,310
Crafty Nectar are a cider subscription service, sourcing ciders from independent producers and delivering to customers UK wide. They have £85k revenue to date and the aim to widen the availability of craft cider for all. They connect people with traditionally made ciders which are often not available in supermarkets. 
days to go: Expired investment: £145,810
SL'M is the world's first zero sugar, zero carb, zero fat range of wines which is approved by both the TSO and FSA. During COVID-19, the company witnessed record earnings, amidst profitable online sales in March 2020. The company has also been featured in publications such as Cosmopolitan, The Sun, and many more. Slim Wine's audience comprises Gen X, Millennials, and Boomers, giving the company a great cross-generational position in the market. The company has served over 2 million glasses of wine and generated profits of over £1 million amidst a growing customer base. Slim Wine's latest vintage, Cuvée 450, was showcased at the 'Royal Berkshire Polo Club'. The company will use the investment to boost sales and marketing, advertising campaigns, and wine production.

Pitch Rated

46%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £262,948
NoshyCircle intends to disrupt the £8.5 billion UK takeaway market by offering healthy home-cooked meals with ingredients and their nutritional value clearly displayed on deliveries. Consumers can use the app to order their meals prepared by cooks in their neighbourhood. NoshyCircle ensures that the cooks are registered with their local council having a food hygiene rating of three or above. The company also strives to make sure that all its deliveries arrive in an eco-friendly packaging and delivery solution. NoshyCircle enables anyone passionate about cooking to register themselves as cooks and start their virtual kitchen. It currently has 20 such people on its platform. NoshyCircle will use the funds to scale its presence to the rest of London by the end of 2021 and expand its social media presence to attract more consumers to grow its business.

Pitch Rated

42%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £91,424
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph